Probabilities of organs at risk damage: History and mathematical models;Probabilités de lésion des organes à risque: historique et principaux modèles mathématiques d'estimation

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 241-245

  Rezvoy, N ^a   Dubray, B ^b  

^a CENTRE OSCAR LAMBRET   (France)

^b CENTRE HENRI BECQUEREL   (France)

Author keywords

Linear quadratic model; Mathematical model; NTCP; Organ at risk; Tolerance

Indexed keywords

MATHEMATICAL ANALYSIS; MEDICAL INFORMATION; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RISK FACTOR; SHORT SURVEY;

ANATOMY; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, THEORETICAL; NEOPLASMS; ORGAN SIZE; PROBABILITY; RADIOBIOLOGY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955327289     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.04.003     Document Type: Short Survey

References (23)

1. Bentzen S.M., Dorr W., Anscher M.S., Denham J.W., Hauer-Jensen M., Marks L.B., et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol 2003, 13:189-202.
2. Burman C., Kutcher G.J., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991, 21:123-135.
3. Chapet O., Kong F.M., Lee J.S., Hayman J.A., Ten Haken R.K. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 2005, 77:176-181.
4. Cosset J.M. Hypofractionnement en radiothérapie: le retour ?. Cancer Radiother 2005, 9:366-373.
5. Delanian S., Lefaix J.L. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 2007, 17:99-107.
6. Dubray B. Complications tardives de la radiothérapie. Rôle des facteurs temps. Bull Cancer Radiother 1995, 82:98-100.
7. Dubray B., Garcia-Ramirez M., Apardian R. Pour une étude nationale prospective de la toxicité pulmonaire de la radiothérapie. Cancer Radiother 2008, 12:134-135.
8. Dubray B.M., Thames H.D. The clinical significance of ratios of radiobiological parameters. Int J Radiat Oncol Biol Phys 1996, 35:1099-1111.
9. Ellis F. Dose, time and fractionation: a clinical hypothesis. Clin Radiol 1969, 20:1-7.
10. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
11. Hendry J.H., Thames H.D. The tissue-rescuing unit. Br J Radiol 1986, 59:628-630.
12. Kallman P., Agren A., Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992, 62:249-262.
13. Kong F.M., Hayman J.A., Griffith K.A., Kalemkerian G.P., Arenberg D., Lyons S., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006, 65:1075-1086.
14. Kutcher G.J., Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989, 16:1623-1630.
15. Lartigau E., Dubray B., Mornex F. Mécanismes biologiques des effets tardifs des radiations ionisantes. Cancer Radiother 1997, 1:669-676.
16. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985, 8:S13-S19.
17. Lyman J.T., Wolbarst A.B. Optimization of radiation therapy. III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 1987, 13:103-109.
18. Malaise E.P., Lambin P., Joiner M.C. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?. Radiat Res 1994, 138:S25-S27.
19. Marples B., Joiner M.C. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiat Res 1993, 133:41-51.
20. Scalliet P., Cosset J.M., Wambersie A. Application of the LQ model to the interpretation of absorbed dose distribution in the daily practice of radiotherapy. Radiother Oncol 1991, 22:180-189.
21. Ten Haken R.K., Lawrence T.S., Dawson L.A. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189-95). Int J Radiat Oncol Biol Phys 2006, 66:1272-1273.
22. Thames H.D., Withers H.R., Peters L.J., Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982, 8:219-226.
23. Yorke E.D., Kutcher G.J., Jackson A., Ling C.C. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 1993, 26:226-237.